ST6Gal-I Sialyltransferase Promotes Chemoresistance in Pancreatic Ductal Adenocarcinoma by Abrogating Gemcitabine-Mediated DNA Damage

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m117.808584
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

HMGA1 Is a Molecular Determinant of Chemoresistance to Gemcitabine in Pancreatic Adenocarcinoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

TRAIL Promotes Metastasis of Human Pancreatic Ductal Adenocarcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Gamma Secretase Inhibition Promotes Hypoxic Necrosis in Mouse Pancreatic Ductal Adenocarcinoma

Journal of Experimental Medicine
MedicineAllergyImmunology
2012English

The BET Inhibitor I-Bet762 Inhibits Pancreatic Ductal Adenocarcinoma Cell Proliferation and Enhances the Therapeutic Effect of Gemcitabine

Scientific Reports
Multidisciplinary
2018English

Cyr61/Ccn1 Regulates dCK and CTGF and Causes Gemcitabine Resistant Phenotype in Pancreatic Ductal Adenocarcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

PSC-induced Galectin-1 Promotes the Malignant Behavior of Pancreatic Ductal Adenocarcinoma

journal of nutritional oncology
2019English

Development and in Vitro Characterization of a Gemcitabine-Loaded MUC4-targeted Immunoliposome Against Pancreatic Ductal Adenocarcinoma

Anticancer Research
MedicineCancer ResearchOncology
2017English

GPRC5A Is a Potential Oncogene in Pancreatic Ductal Adenocarcinoma Cells That Is Upregulated by Gemcitabine With Help From HuR

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2016English

The Anti-Fibrotic Effect of GV1001 Combined With Gemcitabine on Treatment of Pancreatic Ductal Adenocarcinoma

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy